SINAI HEALTH SYSTEM has a total of 29 patent applications. It increased the IP activity by 300.0%. Its first patent ever was published in 2011. It filed its patents most often in United States, EPO (European Patent Office) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are LINEAGE CELL THERAPEUTICS INC, INTERNA TECH B V and JW CREAGENE INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | Canada | 3 | |
#4 | China | 3 | |
#5 | WIPO (World Intellectual Property Organization) | 3 | |
#6 | Australia | 2 | |
#7 | Israel | 2 | |
#8 | Republic of Korea | 2 | |
#9 | Brazil | 1 | |
#10 | United Kingdom | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Measurement | |
#5 | Macromolecular chemistry and polymers |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Object sterilising | |
#5 | Measuring microorganism processes | |
#6 | Peptides | |
#7 | Analysing materials | |
#8 | Fermentation | |
#9 | Implantable devices | |
#10 | Macromolecular compounds compositions |
# | Name | Total Patents |
---|---|---|
#1 | Nagy Andras | 13 |
#2 | Nagy Kristina | 7 |
#3 | Harding Jeffrey | 7 |
#4 | Liang Qin | 6 |
#5 | Monetti Claudio | 6 |
#6 | Orthwein Alexandre | 5 |
#7 | Durocher Daniel | 5 |
#8 | Noordermeer Sylvie | 5 |
#9 | Drabovich Andrei | 2 |
#10 | Jarvi Keith | 2 |
Publication | Filing date | Title |
---|---|---|
WO2020118447A1 | Immunomodulatory cells and uses thereof | |
KR20200016954A | Allogeneic graft resistance without systemic immunosuppression | |
US2017342495A1 | Markers of preterm birth | |
WO2016138574A1 | Homologous recombination factors | |
US2016143745A1 | Intervertebral disc implant | |
US2014112825A1 | Compositions and methods for improving toughness of irradiated sterilized bone allografts | |
EP2555791A1 | Methods for treating disorders of the gastrointestinal tract using a glp-1 agonist |